TCL Archive NCI To Seek Proposals For Less Invasive Detection, Diagnosis, Treatment Technologies July 3, 1998
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Congress: Societies, Advocates, Testify For Increases In Research Funding February 13, 1998
